Disrupted in Renal Carcinoma 2 (DIRC2) (Middle Region) Peptid
DIRC2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle DIRC2 Produkte
- DIRC2 (Disrupted in Renal Carcinoma 2 (DIRC2))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-DIRC2 antibody (Catalog #: ARP50133_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DIRC2 (Disrupted in Renal Carcinoma 2 (DIRC2))
- Synonyme
- MGC80843 Peptide, zgc:92095 Peptide, rcc4 Peptide, MGC69320 Peptide, RCC4 Peptide, disrupted in renal carcinoma 2 Peptide, disrupted in renal carcinoma 2 L homeolog Peptide, disrupted in renal carcinoma 2 (human) Peptide, DIRC2 Peptide, dirc2.L Peptide, dirc2 Peptide, Dirc2 Peptide
- Hintergrund
-
DIRC2 is a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of DIRC2 by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.This gene encodes a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined. Sequence Note: The RefSeq transcript and protein were derived from genomic sequence and transcripts to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments.
Alias Symbols: FLJ14784, RCC4
Protein Size: 478 - Molekulargewicht
- 52 kDa
- Gen-ID
- 84925
- NCBI Accession
- NM_032839, NP_116228
- UniProt
- Q96SL1
-
Sie sind hier:
